Related references
Note: Only part of the references are listed.Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity
Sven Brandt et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Comparative Studies on Branded Enoxaparin and a US Generic Version of Enoxaparin
Jeanine M. Walenga et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2013)
Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: A review of pharmacologic and clinical differences and applications in patients with cancer
Jeanine M. Walenga et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Scientific considerations in the review and approval of generic enoxaparin in the United States
Sau Lee et al.
NATURE BIOTECHNOLOGY (2013)
Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia
M. Margaret Prechel et al.
THROMBOSIS JOURNAL (2013)
Update on the safety and bioequivalence of biosimilars - focus on enoxaparin
Walter Jeske et al.
DRUG HEALTHCARE AND PATIENT SAFETY (2013)
Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay
D. Leroux et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Heparin modifies the immunogenicity of positively charged proteins
Shalini L. Chudasama et al.
BLOOD (2010)
Assessing the immunopotency of Toll-like receptor agonists in an in vitro tissue-engineered immunological model
Yifan Ma et al.
IMMUNOLOGY (2010)
Optimization of a murine immunization model for study of PF4/heparin antibodies
S. Suvarna et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings
A. Greinacher et al.
THROMBOSIS RESEARCH (2008)
Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies
Andreas Greinacher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia
L Rauova et al.
BLOOD (2005)
Comparative tissue factor pathway inhibitor release potential of heparins
M Tobu et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2005)
Anti-inflammatory effects of long-lasting locally-delivered human recombinant tissue factor pathway inhibitor after balloon angioplasty
Y Nakamura et al.
BASIC RESEARCH IN CARDIOLOGY (2002)
Share Paper
